Nuwellis Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Nuwellis Stock Summary

Nuwellis competes with ReShape Lifesciences, Tenon Medical, SINTX Technologies, NanoVibronix, and Tivic Health. Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Nuwellis operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 70 people.

Nuwellis Key Financial Ratios

Nuwellis Key Balance Sheet Accounts

Nuwellis Key Income Statement Accounts

Nuwellis Key Cash Accounts

Nuwellis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nuwellis's current stock value. Our valuation model uses many indicators to compare Nuwellis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nuwellis competition to find correlations between indicators driving Nuwellis's intrinsic value. More Info.Nuwellis is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Nuwellis' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Nuwellis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Nuwellis Systematic Risk

Today, most investors in Nuwellis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nuwellis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nuwellis growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Nuwellis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nuwellis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nuwellis based on widely used predictive technical indicators. In general, we focus on analyzing Nuwellis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nuwellis's daily price indicators and compare them against related drivers.

When running Nuwellis' price analysis, check to measure Nuwellis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuwellis is operating at the current time. Most of Nuwellis' value examination focuses on studying past and present price action to predict the probability of Nuwellis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuwellis' price. Additionally, you may evaluate how the addition of Nuwellis to your portfolios can decrease your overall portfolio volatility.